Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Acinar Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02431676
What this trial is testing

Survivorship Promotion In Reducing IGF-1 Trial

Who this might be right for
Breast CancerProstate CancerLung Cancer+8 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 121
Early research (Phase 1)Study completedNCT02368860
What this trial is testing

OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
National Cancer Centre, Singapore 33
Testing effectiveness (Phase 2)Study completedNCT01591733
What this trial is testing

FOLFIRINOX + RT for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 48
Testing effectiveness (Phase 2)Study completedNCT01869725
What this trial is testing

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

Who this might be right for
Adult MedulloblastomaChildhood MedulloblastomaNeuroblastoma+2 more
Sue O'Dorisio 68
Testing effectiveness (Phase 2)Study completedNCT00191568
What this trial is testing

Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Eli Lilly and Company 45
Not applicableStudy completedNCT01985958
What this trial is testing

A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas

Who this might be right for
Histological or Cytological Diagnosis of Pancreatic Carcinoma
Abramson Cancer Center at Penn Medicine 4
Not applicableUnknownNCT05997147
What this trial is testing

A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma

Who this might be right for
Predictive Cancer ModelPancreas Cancer
Tianjin Medical University Cancer Institute and Hospital 1,009
Testing effectiveness (Phase 2)Study completedNCT03098550
What this trial is testing

Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 105
Very early researchEnded earlyNCT03519308
What this trial is testing

A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Abramson Cancer Center at Penn Medicine 3
Early research (Phase 1)UnknownNCT00639925
What this trial is testing

Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fukushima Medical University 5
Testing effectiveness (Phase 2)Study completedNCT05014776
What this trial is testing

Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Not applicableNot Yet RecruitingNCT07791550
What this trial is testing

Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy

Who this might be right for
Pancreatic NeoplasmsPancreatic CancerDrug-Related Side Effects and Adverse Reactions (MeSH Term)
Tianjin Medical University Cancer Institute and Hospital 96
Testing effectiveness (Phase 2)Ended earlyNCT03785210
What this trial is testing

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerMetastatic Pancreatic Cancer+2 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Study completedNCT05220046
What this trial is testing

Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers

Who this might be right for
Pancreas CancerBiliary Tract CancerPsychological Distress+1 more
University of Nebraska 18
Testing effectiveness (Phase 2)Ended earlyNCT03848182
What this trial is testing

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Albert Einstein College of Medicine 10
Not applicableActive Not RecruitingNCT03022188
What this trial is testing

Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma

Who this might be right for
Neuroendocrine Tumors
Société Française d'Endoscopie Digestive 100
Not applicableStudy completedNCT02517268
What this trial is testing

Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 98
Not applicableStudy completedNCT01038713
What this trial is testing

Plastic vs. Covered Metal vs. Uncovered Metal Biliary Stents for the Management of Malignant Biliary Obstruction

Who this might be right for
Pancreatic Cancer
Dartmouth-Hitchcock Medical Center 94
Not applicableStudy completedNCT00369460
What this trial is testing

Changes in Muscle Tissue in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Case Comprehensive Cancer Center 9
Not applicableUnknownNCT05802420
What this trial is testing

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdvanced CancerMetastatic Cancer
Peking Union Medical College Hospital 100
Next Page